Physician profile
Christopher E Haberman
NPI 1750590931
$20,050.39
in general payments reported to CMS, 2019-2025
94 companies · $3,699 in 2025
The $3,699 reported for 2025 was more than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,707 · 2020: $1,527 · 2021: $2,745 · 2022: $2,898 · 2023: $3,036 · 2024: $3,438 · 2025: $3,699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $34.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,139.00 |
| Education | $34.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,839.15 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,270.64 | 2019-2025 | Imfinzi, Calquence, Lynparza |
| Celgene Corporation | $1,130.15 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Janssen Biotech, INC. | $1,110.92 | 2019-2025 | Erleada, Darzalex, Balversa |
| Regeneron Healthcare Solutions, INC. | $1,038.65 | 2020-2025 | Libtayo |
| Merck Sharp & Dohme LLC | $1,033.81 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| E.R. Squibb & Sons, L.L.C. | $896.29 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Amgen INC. | $807.15 | 2019-2023 | Nplate, Vectibix, Xgeva |
| Daiichi Sankyo INC. | $726.73 | 2019-2025 | Enhertu, Datroway, Injectafer |
| Eisai INC. | $561.60 | 2019-2025 | |
| Genzyme Corporation | $509.73 | 2019-2025 | |
| Astellas Pharma US INC | $491.30 | 2019-2025 | Vyloy, Padcev, Xospata |
| Genentech USA, INC. | $408.59 | 2019-2025 | Polivy, Lunsumio, Columvi |
| Ipsen Biopharmaceuticals, INC | $391.75 | 2019-2025 | Onivyde, Somatuline Depot |
| Glaxosmithkline, LLC. | $385.97 | 2020-2025 | Ojjaara, Jemperli, Zejula |
Show all 93 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $382.56 | 2019-2025 | |
| Incyte Corporation | $366.83 | 2019-2025 | Monjuvi, Jakafi, Zynyz |
| Lilly USA, LLC | $315.44 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Beigene USA, INC. | $314.44 | 2020-2024 | Brukinsa |
| Pharmacyclics LLC, An Abbvie Company | $283.27 | 2019-2023 | Imbruvica |
| Pfizer INC. | $255.02 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $240.46 | 2020-2025 | Ninlaro, Fruzaqla, Iclusig |
| Array Biopharma INC | $213.69 | 2019-2025 | Braftovi, Mektovi, Tukysa |
| Bayer Healthcare Pharmaceuticals INC. | $212.44 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $201.56 | 2020-2025 | Zepzelca |
| Pharmacosmos Therapeutics INC. | $192.60 | 2021-2025 | Monoferric, Cosela |
| Emd Serono, INC. | $189.43 | 2019-2025 | Tepmetko |
| Octapharma USA, INC. | $184.91 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $177.52 | 2020-2025 | Gilotrif |
| Stemline Therapeutics INC. | $170.39 | 2020-2025 | Orserdu |
| Coherus Oncology, INC. | $167.97 | 2020-2025 | Loqtorzi |
| Celltrion USA INC. | $162.97 | 2025 | Vegzelma |
| Puma Biotechnology, INC. | $150.24 | 2019-2025 | Nerlynx |
| Seagen INC. | $149.44 | 2019-2023 | Padcev, Tivdak |
| Aveo Pharmaceuticals, INC. | $128.29 | 2022-2025 | Fotivda |
| Gilead Sciences, INC. | $127.59 | 2021-2025 | Trodelvy |
| Taiho Oncology, INC. | $120.32 | 2019-2025 | |
| Karyopharm Therapeutics INC. | $119.51 | 2021-2023 | Xpovio |
| Mirati Therapeutics, INC. | $116.93 | 2023-2024 | Krazati |
| Kyowa Kirin, INC. | $110.29 | 2019-2025 | |
| Blueprint Medicines Corporation | $102.36 | 2020-2022 | |
| Sobi, INC | $101.55 | 2023-2025 | |
| Exelixis INC. | $100.84 | 2019-2024 | Cabometyx |
| Pharmaessentia USA Corporation | $96.49 | 2024-2025 | Besremi |
| Springworks Therapeutics, INC. | $95.23 | 2024-2025 | Ogsiveo |
| Tersera Therapeutics LLC | $94.82 | 2021-2025 | Quzyttir |
| Tempus Ai, INC | $91.47 | 2025 | Xt Cdx |
| Deciphera Pharmaceuticals INC. | $89.36 | 2021-2025 | Qinlock, Romvimza |
| Beone Medicines USA, INC. | $81.43 | 2025 | Brukinsa, Tevimbra |
| Agios Pharmaceuticals, INC. | $77.46 | 2023-2025 | Pyrukynd |
| G1 Therapeutics, INC. | $74.60 | 2022-2023 | Cosela |
| Csl Behring | $70.64 | 2021-2023 | Afstyla, Idelvion |
| Global Blood Therapeutics, INC. | $66.41 | 2020-2022 | |
| Apellis Pharmaceuticals, INC. | $63.38 | 2023-2024 | Empaveli |
| Progenics Pharmaceuticals, INC. | $55.41 | 2021-2024 | Pylarify |
| Epizyme, INC. | $54.53 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $53.73 | 2021-2025 | Myrisk |
| Morphosys, US INC. | $51.30 | 2022-2023 | Monjuvi |
| Rigel Pharmaceuticals, INC. | $50.93 | 2022-2024 | Rezlidhia, Tavalisse |
| Servier Pharmaceuticals LLC | $50.16 | 2021-2025 | |
| Adc Therapeutics America, INC. | $49.44 | 2021-2023 | |
| Dova Pharmaceuticals | $47.42 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $46.78 | 2019-2020 | |
| Clovis Oncology, INC. | $46.05 | 2019 | |
| Novocure INC. | $40.98 | 2025 | Optune Gio, Optune Lua (Novottf-200t) |
| Foundation Medicine, INC. | $39.78 | 2020 | |
| Tesaro, INC. | $39.62 | 2019 | |
| Amneal Pharmaceuticals LLC | $38.09 | 2025 | Alymsys |
| Caris Mpi, INC. | $35.16 | 2025 | Mi Cancer Seek |
| Acceleron Pharma, INC. | $31.96 | 2021 | |
| Aurobindo Pharma USA, INC. | $30.74 | 2020 | |
| Eusa Pharma (US) LLC | $28.79 | 2022 | |
| Shire North American Group INC | $28.24 | 2019 | |
| Heron Therapeutics, INC. | $27.22 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $26.98 | 2019-2021 | |
| Adaptive Biotechnologies Corporation | $26.24 | 2022-2023 | Clonoseq |
| Syndax Pharmaceuticals, INC. | $25.12 | 2025 | |
| Emmaus Medical, INC. | $23.15 | 2020 | |
| Sanofi-Aventis U.S. LLC | $22.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $20.91 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $20.53 | 2024 | Ultomiris |
| Genmab U.S., INC. | $18.11 | 2023 | Epkinly |
| Immunogen, INC. | $17.68 | 2024 | Elahere |
| Corcept Therapeutics | $17.11 | 2025 | Korlym |
| Tg Therapeutics, INC. | $16.92 | 2022 | |
| Acrotech Biopharma INC. | $16.42 | 2023 | Beleodaq |
| Alnylam Pharmaceuticals INC. | $14.85 | 2021 | |
| Immunocore Limited | $14.51 | 2024 | Kimmtrak |
| Sumitomo Pharma America, INC. | $13.75 | 2023 | Orgovyx |
| Iovance Biotherapeutics, INC. | $13.19 | 2025 | Amtagvi |
| Verastem, INC. | $11.40 | 2020 | |
| Kite Pharma, INC. | $11.34 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.27 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Libtayo $752Reblozyl $561Enhertu $457Keytruda $388Opdivo $364Kisqali $269Lynparza $264Brukinsa $240Imbruvica $227Scemblix $216Onivyde $199Lenvima $189Zepzelca $182Krazati $176Jaypirca $174Verzenio $174Pluvicto $169Imfinzi $169Vegzelma $163Sarclisa $162Calquence $162Erleada $159Padcev $158Somatuline Depot $149Monjuvi $149Darzalex $143Orserdu $139Ninlaro $127Mektovi $127Braftovi $127Balversa $126Polivy $123Pomalyst $120Monoferric $117Retevmo $116Talvey $109Ojjaara $108Tecvayli $104Lunsumio $103Elahere $100Fotivda $98.84Vitrakvi $98.10Stivarga $98.10Epkinly $97.45Akeega $97.35Besremi $96.49Jakafi $96.26Ogsiveo $95.23Rybrevant $93.61Xt Cdx $91.47Opdualag $88.82Columvi $88.13Fabhalta $83.36Trodelvy $80.62Doptelet $80.09Nubeqa $77.82Cosela $77.01Tasigna $76.12Jemperli $75.56Vyloy $75.22Piqray $74.27Lutathera $73.45Mekinist $70.59Udenyca $67.70Zynyz $66.29Tukysa $66.22Empaveli $63.38Pyrukynd $61.24Venclexta $60.90Lorbrena $60.37Nerlynx $59.64Promacta $56.44Idelvion $55.36Afstyla $55.36Xpovio $54.32Quzyttir $52.39Fruzaqla $50.69Keytruda Qlex $48.24Datroway $44.70Pemazyre $41.65Xalkori $41.51Pylarify $41.51Alymsys $38.09Xospata $37.02Oxbryta $36.82Cabometyx $36.64Zejula $36.62Xofigo $35.82Mi Cancer Seek $35.16Phesgo $34.93Tavalisse $33.57Rezlidhia $33.57Injectafer $33.40Tecentriq $32.36Myrisk $30.17Carvykti $29.57Adcetris $28.78Elrexfio $28.78Bosulif $28.78Welireg $24.29
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Haberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.